March 4, 2026

SII joins CEPI

  • The Serum Institute of India (SII) is joining the Coalition for Epidemic Preparedness Innovations-
  • CEPI will invest $30 million to build upon SII’s capabilities to supply affordable investigational vaccines in any epidemic or pandemic.
SII is the world’s largest vaccine manufacturer and has an overall production capacity of 4 billion doses annually.

ABOUT CEPI

  • It is a partnership between public, private, philanthropic, and civil organisations, launched at Davos, Switzerland, in 2017.
  • It aims to finance and coordinate the development of new vaccines to prevent and contain infectious disease epidemics.
  • Headquarters– Oslo, Norway.
  • Mission- accelerate the development of vaccines and other biologic countermeasures against epidemics like- Nipah Virus, Lassa fever Vaccine
  • It is being funded by the Wellcome Trust, Bill and Melinda Gates Foundation, World Economic Forum (WEF), Governments of Norway, Japan, India (Department of Biotechnology) and Germany.

© 2026 Civilstap Himachal Design & Development